{"title":"Patienten mit Typ-1-Diabetes profitieren von Typ-2-Medikation","authors":"Robert Bublak, Wolfgang Geissel","doi":"10.1007/s15034-023-4576-4","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":491124,"journal":{"name":"Info Diabetologie","volume":" 17","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Info Diabetologie","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.1007/s15034-023-4576-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}